What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research

被引:92
|
作者
Kusters, Miranda
Slater, Andrew
Muirhead, Rebecca
Hompes, Roel
Guy, Richard J.
Jones, Oliver M.
George, Bruce D.
Lindsey, Ian
Mortensen, Neil J.
Cunningham, Chris
机构
[1] Department of Surgery, Catharina Hospital, Postbox 1350, ZA Eindhoven
[2] Department of Surgery, Leiden University Medical Centre, Leiden
[3] Department of Radiology, Oxford University Hospitals NHS Foundation Trust
[4] CRUK MRC Oxford Institute for Radiation Oncology, Oxford University Hospitals NHS Foundation Trust
[5] Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust
关键词
Chemoradiotherapy; Local recurrence; Magnetic resonance imaging; Rectal cancer; Lateral lymph nodes; Total mesorectal excision; PREOPERATIVE CHEMORADIOTHERAPY; CURATIVE RESECTION; RECURRENCE; DISSECTION; RADIOTHERAPY; PERIOD;
D O I
10.1097/DCR.0000000000000834
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: There remains a lack of international consensus on the appropriate management of lateral nodal disease. Although the East manages this more aggressively with lateral lymph node dissections, the West aims to eradicate small-volume disease with neoadjuvant chemoradiotherapy and lateral nodal disease is not considered for routine surgical treatment. However, recent studies have shown that, despite neoadjuvant treatment, a significant number of patients with lateral nodal disease develop local recurrence in the lateral compartment after total mesorectal excision. OBJECTIVE: The aim of this study is to assess the role of the pretreatment features of lateral nodes on MRI in regard to local recurrence. DESIGN: All patients operated on for low locally advanced rectal cancer over a 5-year period were evaluated retrospectively. SETTINGS: This study was conducted at a single expert center. PATIENTS: The MRIs of a total of 313 patients were reviewed, and only those with rectal cancers up to 8 cm from the anorectal junction, measured on MRI, were selected. This left 185 patients; of these, 58 patients had clinical T1 or T2 tumors as assessed on MRI, identifying 127 patients who had cT3/T4 tumors that were included in this study. MAIN OUTCOME MEASURES: The primary outcomes measured were lateral local recurrence and multivariate analyses. RESULTS: The lateral local recurrence rate was significantly higher (33.3% 4-year rate) in patients with nodes larger than 10 mm than in patients with smaller nodes (10.1%, p = 0.03), despite patients being irradiated in the lateral compartment. LIMITATIONS: Because this is a relatively uncommon disease, patient numbers are low, and a multicenter study is needed to further address lateral nodal disease in low rectal cancer. CONCLUSIONS: Chemoradiotherapy with total mesorectal excision might not be sufficient in a selected group of patients. Further research is needed about which pretreatment features of the lateral nodes predict local recurrence and what is needed to prevent these from developing. See Video Abstract at http://links.lww.com/DCR/A338.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [11] Selective neoadyuvant therapy in locally advanced rectal cancer: For whom and with what aim?
    Ximenez, Eduardo Garcia-Granero
    Ruiperez, Andres Cervantes
    CIRUGIA ESPANOLA, 2023, 101 (05): : 309 - 311
  • [12] What helps in locally advanced rectal cancer?
    Ulrich, Alexis
    Lammers, Bernhard
    Henn, Sandra
    COLOPROCTOLOGY, 2022, 44 (04) : 229 - 234
  • [13] The awareness of radiologists for the presence of lateral lymph nodes in patients with locally advanced rectal cancer: a single-centre, retrospective cohort study
    Sluckin, T. C.
    Rooker, Y. F. L.
    Kol, S. Q.
    Hazen, S. J. A.
    Tuynman, J. B.
    Stoker, J.
    Tanis, P. J.
    Horsthuis, K.
    Kusters, M.
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 6637 - 6645
  • [14] Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy
    Akiyoshi, Takashi
    Yamaguchi, Tomohiro
    Hiratsuka, Makiko
    Mukai, Toshiki
    Hiyoshi, Yukiharu
    Nagasaki, Toshiya
    Ueno, Masashi
    Fukunaga, Yosuke
    Konishi, Tsuyoshi
    EJSO, 2021, 47 (12): : 3157 - 3165
  • [15] The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes
    Meldolesi, Elisa
    Chiloiro, Giuditta
    Giannini, Roberta
    Menghi, Roberta
    Persiani, Roberto
    Corvari, Barbara
    Coco, Claudio
    Manfrida, Stefania
    Ratto, Carlo
    De Luca, Viola
    Sofo, Luigi
    Reina, Sara
    Crucitti, Antonio
    Masiello, Valeria
    Dinapoli, Nicola
    Valentini, Vincenzo
    Gambacorta, Maria Antonietta
    CANCERS, 2022, 14 (07)
  • [16] A multistate survival model in rectal cancer surgery research for locally advanced patients
    Shahabi, Fatemeh
    Abdollahi, Abbas
    Rasouli, Mahboobeh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2024, 29 (01):
  • [17] What Predicts Complete Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer?
    Yilmaz, Sumeyye
    Liska, David
    Conces, Madison
    Tursun, Naz
    Elamin, Doua
    Ozgur, Ilker
    Maspero, Marianna
    Rosen, David
    Khorana, Alok
    Balagamwala, Ehsan
    Amarnath, Sudha
    Valente, Michael
    Steele, Scott
    Krishnamurthi, Smitha
    Gorgun, Emre
    DISEASES OF THE COLON & RECTUM, 2025, 68 (01) : 60 - 68
  • [18] What is the Significance of the Circumferential Margin in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy?
    Atthaphorn Trakarnsanga
    Mithat Gonen
    Jinru Shia
    Karyn A. Goodman
    Garrett M. Nash
    Larissa K. Temple
    José G. Guillem
    Philip B. Paty
    Julio Garcia-Aguilar
    Martin R. Weiser
    Annals of Surgical Oncology, 2013, 20 : 1179 - 1184
  • [19] Laparoscopic abdominoperineal resection with intraoperative radiotherapy for locally advanced low rectal cancer
    Skrovina, Matej
    Soumarova, Renata
    Duda, Miloslav
    Bezdek, Roman
    Bartos, Jiri
    Wendrinski, Adam
    Andel, Petr
    Parvez, Javed
    Straka, Martin
    Adamcik, Lukas
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (03): : 447 - 450
  • [20] Locally Advanced Rectal Cancer, What is the Standard of Care?
    Copur, Mehmet Sitki
    Wedel, Whitney
    Jonglertham, Pornchai
    Zusag, Thomas
    Horn, Adam
    ONCOLOGY-NEW YORK, 2020, 34 (01): : 16 - 19